Cyklokapron
Developed to manage heavy menstrual bleeding, utilized to support patients in reducing blood loss during menstruation.
Strengths: 500mg
Where to Check Availability
Medicine details
- Conditions
- Alternative names
Cyclokapron
- Therapeutic class
Antifibrinolytic
- Pharmacological class
Antifibrinolytic
- Minor side effects
nausea; diarrhoea; vomiting
- Moderate side effects
dizziness; hypotension
- Dosage forms
Tablet
- Administration route
Oral use
- Prescription status
POM
- Manufacturer
Pfizer
- Onset Time
1–2 hours
- Duration
6–8 hours
- Storage instructions
Store in a cool, dry place away from direct light.
- Drug interactions
hormonal contraceptives; thrombolytics
- Age restrictions
Adults
Contraindications
hypersensitivity to tranexamic acid; history of venous thromboembolism; history of arterial thromboembolism
Precautions and warnings
use with caution in patients with renal impairment; report any visual disturbances immediately
Serious side effects
thromboembolism — requires immediate medical attention; convulsions — requires immediate medical attention
Patient summary
Developed to manage heavy menstrual bleeding, utilized to support patients in reducing blood loss during menstruation.
Mechanism of action
Cyklokapron works by preventing the breakdown of blood clots. By inhibiting plasminogen activation to plasmin, it stabilizes formed clots, which helps to control excessive bleeding.
Pregnancy and breastfeeding
Pregnancy: Use only if the potential benefit justifies the potential risk to the fetus. Breastfeeding: Tranexamic acid is excreted in breast milk; consult your healthcare provider.
Cyklokapron
Developed to manage heavy menstrual bleeding, utilized to support patients in reducing blood loss during menstruation.
Editorial Notes
- Active ingredient(s): Tranexamic Acid
- Listed indication(s): Menorrhagia, Haemorrhage
Available option
- 30 tablets - 500 mg800-500-mg-15595